<p>Dementia poses a significant global health challenge, with increasing impact on individuals and healthcare systems. This study aims to investigate the metabolic profiles of clinical Alzheimer’s disease (AD) and vascular dementia (VaD) patients in Egypt, seeking to identify connections between metabolic disruptions and environmental factors. Utilizing serum samples from 61 AD patients and 76 VaD patients compared to 100 healthy controls, the research employed untargeted LC-MS and generalized regression analysis. The findings revealed significant alterations in 59 metabolites in AD patients and 69 in VaD patients, including environmental contaminants. Additionally, pathway enrichment analysis indicated distinct metabolic pathways affected in each group, such as amino acid metabolism in AD and purine metabolism in VaD. This research provides insights into the biological pathways and environmental agents linked to dementia, highlighting the need for diverse populations in metabolomic studies to improve prevention and intervention strategies globally.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Metabolomic profiling of a dementia cohort in Egypt: a step towards a neuro-exposome model

  • Mai Othman,
  • Eman Khedr,
  • Shimaa Heikal,
  • Gharib Fawi,
  • Sara Elfarrash,
  • Samer Salama,
  • Muhammad Abdelshafi,
  • Nesma G. Elsheikh,
  • Heba M. Tawfik,
  • Hany I. Hassanin,
  • Noha Abo Elftoh,
  • Shady Safwat,
  • Esraa Ali,
  • Mostafa Saber,
  • Abdullah Lomomba Mohamed,
  • Ahmed Shoyb,
  • Amna Ibrahim,
  • Ahmed Qayaty,
  • Eman M. Ali,
  • Samir Shamma,
  • Ayman A. Saeed,
  • Ashraf Eltaher,
  • Noha A. Yousri,
  • Mohamed Salama

摘要

Dementia poses a significant global health challenge, with increasing impact on individuals and healthcare systems. This study aims to investigate the metabolic profiles of clinical Alzheimer’s disease (AD) and vascular dementia (VaD) patients in Egypt, seeking to identify connections between metabolic disruptions and environmental factors. Utilizing serum samples from 61 AD patients and 76 VaD patients compared to 100 healthy controls, the research employed untargeted LC-MS and generalized regression analysis. The findings revealed significant alterations in 59 metabolites in AD patients and 69 in VaD patients, including environmental contaminants. Additionally, pathway enrichment analysis indicated distinct metabolic pathways affected in each group, such as amino acid metabolism in AD and purine metabolism in VaD. This research provides insights into the biological pathways and environmental agents linked to dementia, highlighting the need for diverse populations in metabolomic studies to improve prevention and intervention strategies globally.